Table 2.
Coagulation status.
| Variable | Patient values | Reference interval (unit) | |
|---|---|---|---|
| Platelet count admission | 212 (175–248) | 145–348 (109/l) | |
| APTT admission | 31 (29–36) | 28–40 (s) | |
| Missing | 9 (5) | ||
| INR admission | 1.1 (1–1.2) | <1.2 (INR) | |
| Missing | 6 (3) | ||
| ASPI, first value | 51 (23.5–79) | 71–115; 65–119 (AU) | |
| ADP, first value | 51 (31–69) | 57–113; 57–113 (AU) | |
| TRAP, first value | 95 ± 35.6 | 84–128; 84–128 (AU) | |
| Missing | 1 (0.56) | ||
| Platelet transfusion | Transfused | 112 (63) | |
| Missing | 4 (2) | ||
| Platelet transfusion dose | Volume | 600 (0–1,142) | (ml) |
| Missing | 10 (5.6) | ||
| Erythrocyte transfusion | Transfused | 102 (57) | |
| Fresh frozen plasma transfusion | Transfused | 80 (45) | |
| COX inhibitor treatment | Treatment before admission | 42 (24) | |
| ADP inhibitor treatment | Treatment before admission | 5 (2.8) |
In total, 178 patients were included. Data are depicted as count (%) if categorical and otherwise as median (interquartile range), or mean ± SD, if continuous. When applicable, reference intervals are reported as those that at the time point of the study were used at the Karolinska University Hospital. Measurement units are given in parentheses next to the reference interval value. MEA measurements were obtained using two different devices, which had slightly different reference intervals, both of which are reported.
ADP, P2Y12 receptor; APTT, activated partial thromboplastin time; ASPI, arachidonic acid receptor; AU, area under the curve; COX, cyclooxygenase; INR, international normalized ratio; TRAP, thrombin receptor; MEA, multiple electrode aggregometry.